In this part of the trial, as expected, brodalumab showed the most benefit in the ACR20 of those previously on placebo
Neurological symptoms often develop gradually and may include: Paraesthesia : tingling or 'pins and needles' sensations, typically starting in the feet and hands Numbness : reduced sensation in the extremities, which may affect balance and coordination Burning pain : particularly in the feet, often worse at night Weakness : muscle weakness and difficulty walking Balance problems : unsteady gait and increased fall risk due to proprioceptive impairment Cognitive changes : memory problems, confusion, difficulty concentrating, and mood disturbances Haematological signs may accompany neurological symptoms and include fatigue, weakness, pallor, and shortness of breath due to megaloblastic anaemia
Boron influences calcium and magnesium metabolism and may enhance the effects of vitamin D
Oral Administration Discussed on the basis of BPC-157s demonstrated resistance to gastric acid degradation
By stimulating cell growth and increasing blood flow, BPC-157 accelerates the healing process, allowing you to recover faster and return to normal activities sooner.BPC-157 promotes tissue repair, leading to improved function and reduced pain
